China’s Institute of Materia Medica Partners With Cyclica on Innovative Drug Repurposing for COVID-19
TORONTO & BEIJING--(BUSINESS WIRE)--#artificialintelligence--The epidemic of COVID-19 remains a prominent healthcare challenge, affecting more than…